Literature DB >> 1371304

Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27.

S E Buxton1, R J Benjamin, C Clayberger, P Parham, A M Krensky.   

Abstract

Dissection of the peptide binding grooves of seven subtypes of human histocompatibility leukocyte antigen (HLA)-B27 into the six specificity pockets defined by the 2.6-A structure of HLA-A*0201 revealed just one pocket, the B ("45") pocket, that is conserved among all the HLA-B27 subtypes. Functional studies of mutant HLA-B*2705 molecules with point substitutions in residues of the B pocket show that this structure, and the glutamine residue at position 45 in particular, plays a critical role in cell surface expression, peptide binding, and in the presentation of both exogenous and endogenous peptides by HLA-B*2705. We predict that the B pocket of HLA-B*2705 interacts with an amino acid side chain that anchors peptides in the binding groove, and that this peptide motif is present in most endogenously processed peptides that bind to all seven subtypes of HLA-B27.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371304      PMCID: PMC2119159          DOI: 10.1084/jem.175.3.809

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Alloreactive T cells discriminate among a diverse set of endogenous peptides.

Authors:  W R Heath; K P Kane; M F Mescher; L A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

2.  The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.

Authors:  C C Winter; B M Carreno; R V Turner; S Koenig; W E Biddison
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

3.  HLA class I nucleotide sequences, 1991.

Authors:  J Zemmour; P Parham
Journal:  Immunobiology       Date:  1991-06       Impact factor: 3.144

4.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

5.  Empty MHC class I molecules come out in the cold.

Authors:  H G Ljunggren; N J Stam; C Ohlén; J J Neefjes; P Höglund; M T Heemels; J Bastin; T N Schumacher; A Townsend; K Kärre
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

6.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68.

Authors:  T P Garrett; M A Saper; P J Bjorkman; J L Strominger; D C Wiley
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

Review 7.  HLA-B27 and HLA-A2 subtypes: structure, evolution and function.

Authors:  J A López de Castro
Journal:  Immunol Today       Date:  1989-07

8.  In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.

Authors:  F A el-Zaatari; K C Sams; J D Taurog
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

9.  Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.

Authors:  S Huet; D F Nixon; J B Rothbard; A Townsend; S A Ellis; A J McMichael
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

10.  Molecular analysis of the variant alloantigen HLA-B27d (HLA-B*2703) identifies a unique single amino acid substitution.

Authors:  S Y Choo; T St John; H T Orr; J A Hansen
Journal:  Hum Immunol       Date:  1988-03       Impact factor: 2.850

View more
  19 in total

Review 1.  HLA-B27 subtypes: implications for the spondyloarthropathies.

Authors:  L MacLean
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

2.  Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.

Authors:  R A Colbert; S L Rowland-Jones; A J McMichael; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

3.  Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus.

Authors:  C E Hioe; D M McKinney; J A Frelinger; M McMillan
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones.

Authors:  M Matsui; C E Hioe; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

5.  HLA-B27 subtypes in the spondarthropathies.

Authors:  I L MacLean; S Iqball; P Woo; A C Keat; R A Hughes; G H Kingsley; S C Knight
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

6.  HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides.

Authors:  D Fruci; P Rovero; R H Butler; R Sorrentino; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

7.  The peptide binding specificity of HLA-B27 subtypes.

Authors:  N Tanigaki; D Fruci; E Vigneti; G Starace; P Rovero; M Londei; R H Butler; R Tosi
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  Computer simulations to identify in polyproteins of FMDV OK1 and A12 strains putative nonapeptides with amino acid motifs for binding to BoLA class I A11 and A20 haplotype molecules.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 9.  HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

Review 10.  The pathogenetic aspects of spondyloarthropathies from the point of view of HLA-B27.

Authors:  H Kellner; D Yu
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.